Anti-carbamylated protein antibodies as a clinical response predictor in rheumatoid arthritis patients treated with abatacept-Reference-Cited by-同舟云学术

Anti-carbamylated protein antibodies as a clinical response predictor in rheumatoid arthritis patients treated with abatacept

Published:2021-02-05 Issue:1 Volume:39 Page:91-97
ISSN:1593-098X
Container-title:Clinical and Experimental Rheumatology
language:en
Short-container-title:

Author:

Kumar Rajesh¹,Piantoni Silvia²,Boldini Michele¹,Garrafa Emirena³,Bazzani Chiara¹,Fredi Micaela¹,Ottaviani Roberta¹,Cavazzana Ilaria¹,Tincani Angela¹,Franceschini Franco¹

Affiliation:

1. Rheumatology and Clinical Immunology Unit, Department of Clinical and Experimental Sciences, ASST Spedali Civili and University of Brescia, Italy.

2. Rheumatology and Clinical Immunology Unit, Department of Clinical and Experimental Sciences, ASST Spedali Civili and University of Brescia, Italy. slv.piantoni@gmail.com

3. Department of Molecular and Translational Medicine, University of Brescia, Italy.

Publisher

Clinical and Experimental Rheumatology

Subject

Immunology,Immunology and Allergy,Rheumatology

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Towards Personalized Medicine in Rheumatoid Arthritis;Open Access Rheumatology: Research and Reviews;2024-05

2. Reproductive Effect by Rheumatoid Arthritis and Related Autoantibodies;Rheumatology and Therapy;2024-02-20

3. Distribution and clinical significance of anti-carbamylation protein antibodies in rheumatological diseases among the Chinese Han population;Frontiers in Immunology;2023-07-19

4. Pre-Rheumatoid Arthritis: A Review;Journal of Clinical Rheumatology and Immunology;2023-07

5. Tailored therapeutic decision of rheumatoid arthritis using proteomic strategies: how to start and when to stop?;Clinical Proteomics;2023-06-10